Ongoing Phase I/II Prevention Trials Funded and Monitored by the Breast and Gynecologic Cancer Research Group (BGCRG)
** indicates studies that are open to accrual
The University of Texas MD Anderson Cancer Center: Hereditary Gynecologic Cancers